The Programme continues to receive exceptional support both from high-income countries and from LMICs. This is seed money and the aim is for the project to be self-sustaining after 2026. Funds are used to cover the overall coordination of the project, the establishment of the mRNA Consortium activities in South Africa, the development of innovation and products and to directly support the Programme Partners for technology transfer. A large portion of the funds has been secured.
Phase 1.0 Funders (2021–2026) The table below presents the financial contributions received in support of the mRNA Technology Transfer Programme during Phase 1.0 (2021–2026).
Phase 2.0 Funding (2027–2030) Information on funding contributions and partners supporting Phase 2.0 of the mRNA Technology Transfer Programme will be made available soon.